Actively Recruiting

Age: 50Years +
All Genders
Healthy Volunteers
ID07281794

Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease

Led by Northumbria University · Updated on 2026-02-12

60

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

N

Northumbria University

Lead Sponsor

D

DANU Sports Ltd

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to explore the use of DANU Smart Socks for assessing walking and balance in people with Parkinson's disease (PwP). The study compares gait and balance data from PwP and healthy individuals of similar age to see if these measurements relate to Parkinson's symptoms such as disease progression and cognitive function. It is an observational study involving one laboratory visit. Participants include people diagnosed with Parkinson's disease and healthy age-matched controls, all aged 50 or older. During the visit, participants complete clinical and cognitive tests including the Unified Parkinson's Disease Rating Scale, Montreal Cognitive Assessment, Freezing of Gait Questionnaire, and Falls Efficacy Scale. Movement is assessed using the DANU system alongside APDM Mobility Lab through tasks like a 2-Minute Walk Test, walkway trials, Timed Up and Go, and balance tasks. Participants attend one visit where clinical scales, cognitive tests, and mobility assessments are conducted. Researchers collect detailed gait and balance outcomes such as stride length, step time, cadence, ground contact time, and range of motion in one session. These data help understand links between walking patterns and Parkinson's symptoms. The study ends after this single visit, with no long-term follow-up described.

CONDITIONS

Brief Title

Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease

Who Can Participate

Age: 50Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis of Parkinson's disease by a movement disorder specialist according to UK brain bank criteria (for Parkinson's group)
  • Hoehn and Yahr stages I-III (for Parkinson's group)
  • Ability to attend Northumbria University for study visit
  • Able to walk and stand unassisted for at least 2 minutes
  • Aged 50 years or older
  • Ability to attend Northumbria University for study visit (for healthy controls)
  • Aged 50 years or older (for healthy controls)
  • Able to walk and stand unassisted for at least 2 minutes (for healthy controls)
Not Eligible

You will not qualify if you...

  • History of neurological disorders other than Parkinson's disease (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease)
  • Unable to walk or stand unaided
  • Montreal Cognitive Assessment score below 21
  • Significant non-Parkinson's issues affecting gait (e.g., musculoskeletal problems, back pain, recent surgery)
  • History of neurological disorders (for healthy controls)
  • Significant issues affecting walking (for healthy controls)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants attend one visit to complete clinical and cognitive assessments and perform motor tasks using the DANU Sports System and APDM Mobility Lab for gait and balance evaluation.

1 visit (in-person)

Trial Site Locations

Total: 2 locations

1

Northumbria University

Newcastle upon Tyne, Tyne and Wear, United Kingdom

Actively Recruiting

2

Northumbria University

Newcastle upon Tyne, United Kingdom

Enrolling by Invitation

Loading map...

Research Team

G

Gabriella R Gatti, BSc

R

Rodrigo Vitorio, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evalu...

Parkinson Disease (PD)

Actively Recruiting

1 location

Clinical Research on Optimization of Acute Levodopa Challeng...

Vascular Parkinsonism

Actively Recruiting

1 location

Changes in Motor Function, Quality of Life, Cardiorespirator...

Parkinson Disease (PD)

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here